Back to search

Article

The effect of PARPi maintenance therapy on re-chemotherapy in advanced ovarian cancer

2023-12-06

Abstract excerpt

<h4>Purpose: </h4> Study on whether PARPi maintenance therapy has an impact on the subsequent chemotherapy efficacy of recurrent ovarian cancer in advanced ovarian cancer. Methods 111 patients with first platinum-sensitive recurrent ovarian cancer were collected, 49 patients were treated with PARPi maintenance therapy after first-line treatment, and 62 patients were not treated with PARPi maintenance therapy. Gen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
985a3822-2070-52bb-8b3b-f1f9a5e4bce3
DOI
10.21203/rs.3.rs-3692029/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The effect of PARPi maintenance therapy on re-chemotherapy in advanced ovarian cancerDOI 10.21203/rs.3.rs-3692029/v1
PARPis after PARPis in patients with recurrent epithelial ovarian cancer: A single institutional experienceSemantic proximity
Effects of PARP Inhibitors on Subsequent Platinum-Based Chemotherapy in Patients with Recurrent Ovarian CancerSemantic proximity
Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives - a review.Semantic proximity
A real-world study of treatment patterns following disease progression in epithelial ovarian cancer patients undergoing poly-ADP-ribose polymerase inhibitor maintenance therapySemantic proximity
Poly (ADP-Ribose) polymerase inhibitors have efficacy in a fraction of platinum-resistant ovarian cancer patientsSemantic proximity
Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis.Semantic proximity
Real-world treatment patterns of maintenance therapy in platinum-sensitive recurrent ovarian cancer.Semantic proximity
Molecular and clinical predictors of improvement in progression‐free survival with maintenance PARP inhibitor therapy in women with platinum‐sensitive, recurrent ovarian cancer: A meta‐analysisSemantic proximity
Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study.Semantic proximity
Recurrent Ovarian Cancer in BRCAness Phenotype: A Treatment ChallengeSemantic proximity
The Diagnostic Value of DNA Repair Gene in Breast Cancer Recurrence and MetastasisSemantic proximity
Long-term progression-free survivors ("super responders") to olaparib maintenance in recurrent ovarian cancer: a multicenter real-world study (KCOG-G2101s).Semantic proximity
Select a neighboring publication to make it the new centre.